for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Unichem Laboratories Limited

UNLB.NS

Latest Trade

149.75INR

Change

7.15(+5.01%)

Volume

85,014

Today's Range

141.30

 - 

151.00

52 Week Range

141.30

 - 

224.90

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Unichem Laboratories Says U.S. FDA's Inspection At Kolhapur Facility Ends Without Any Form 483 Issued

Sept 20 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::UNICHEM LABORATORIES LTD - ACTIVE PHARMACEUTICAL INGREDIENTS FACILITY AT KOLHAPUR INSPECTED BY U.S. FDA AND CONCLUDED WITHOUT ANY FDA FORM 483 ISSUED.

Unichem Laboratories Gets Receives ANDA Nod From USFDA For Solifenacin Succinate Tablets

Aug 28 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::UNICHEM RECEIVES ANDA APPROVAL FROM USFDA FOR SOLIFENACIN SUCCINATE TABLETS, 5 MG AND 10 MG.

India's Unichem Gets 1 Observation From USFDA Inspection Of Ghaziabad Unit

Aug 26 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::U.S. FDA INSPECTED COMPANY'S GHAZIABAD FORMULATION FACILITY BETWEEN AUGUST 19, 2019 TO AUGUST 23, 2019.INSPECTION WAS A ROUTINE GMP SURVEILLANCE.AT END OF INSPECTION, FACILITY RECEIVED 1 OBSERVATION WHICH IS NOT A REPEAT OBSERVATION AND IS PROCEDURAL IN NATURE.

Unichem Laboratories Says Goa Facility Got 4 Observations After USFDA Inspection

July 31 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::USFDA INSPECTED COMPANY'S GOA FORMULATION FACILITY BETWEEN JULY 22 TO JULY 31, 2019.FACILITY RECEIVED 4 OBSERVATIONS, WITH NO REPEAT OBSERVATIONS AND ARE MOSTLY PROCEDURAL IN NATURE.

Unichem Laboratories March-qtr Profit Surges

May 24 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::RECOMMENDED DIVIDEND OF 4 RUPEES PER SHARE.MARCH QUARTER PROFIT 99.4 MILLION RUPEES VERSUS PROFIT 22.5 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.77 BILLION RUPEES VERSUS 2.03 BILLION RUPEES YEAR AGO.

Unichem Laboratories Gets Final Approval For Tadalafil Tablets From U.S FDA

March 27 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::GETS FINAL APPROVAL FOR ITS ANDA, TADALAFIL TABLETS, 2.5 MG, 5 MG 10 MG AND 20 MG FROM U.S FDA.

Unichem Laboratories Gets ANDA Approval From USFDA For Allopurinol Tablets

March 13 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::GETS ANDA APPROVAL FROM USFDA FOR UNICHEM'SALLOPURINOL TABLETS, USP 100 MG AND 300 MG.

Unichem Laboratories Gets ANDA Approval For Allopurinol Tablets From USFDA

March 13 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::UNICHEM LABORATORIES -GETS ANDA APPROVAL FOR ALLOPURINOL TABLETS, USP 100 MG AND 300 MG FROM USFDA TO MARKET GENERIC VERSION OF ZYLOPRIM TABLETS.

Unichem Laboratories Says EU Court Rejects Appeal On Decision Of Breach Of EU Competition Law

Dec 13 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::GENERAL COURT OF EUROPEAN UNION REJECTED CO'S APPEAL ON COURT DECISION ON BREACH OF EU COMPETITION LAW.GENERAL COURT OF EUROPEAN UNION HAS ALSO CONFIRMED FINE OF 13.96 MILLION EUROS.

India's Unichem Laboratories Gets Tentative ANDA Approval From U.S FDA For Tadalafil Tablets

Dec 11 (Reuters) - Unichem Laboratories Ltd <UNLB.NS>::GETS TENTATIVE ANDA APPROVAL FROM USFDA FOR,UNICHEM'S TADALAFIL TABLETS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up